AHA Urges CMS Not to Finalize Provisions in FY 2027 Inpatient Psychiatric Facility Proposed Rule

Why It Matters

If CMS adopts the current proposals, psychiatric hospitals could face higher operating costs and administrative burdens, potentially limiting access to inpatient mental health care and straining provider finances.

Key Takeaways

• AHA warns CMS market basket update is insufficient for FY 2027
• AHA urges reduction of high productivity adjustment in IPF payments
• AHA recommends delaying outlier payment cap pending cost analysis
• AHA calls for postponing IPF-PAI rollout due to provider burden

Pulse Analysis

The CMS‑proposed FY 2027 IPF prospective payment rule represents the latest effort to align Medicare reimbursement with evolving cost structures in psychiatric care. While the agency aims to modernize payment methodology, the AHA’s critique highlights a fundamental disconnect: the market‑basket forecast appears to lag behind real‑world expense growth, especially for labor and supply inputs that have surged post‑pandemic. By urging a recalibration of the productivity adjustment, the AHA seeks to prevent a de‑facto rate cut that could erode hospital margins and force facilities to curtail services or seek supplemental funding.

Beyond the headline numbers, the AHA’s push to delay the outlier payment cap and the IPF‑PAI rollout underscores concerns about administrative overload. Outlier payments are intended to cushion unusually costly stays, yet a premature cap could leave hospitals bearing the full brunt of high‑intensity cases, such as those involving comorbid substance‑use disorders. Similarly, the IPF‑PAI, while designed to improve quality measurement, may require extensive data collection and reporting infrastructure that smaller providers lack, inflating overhead without demonstrable patient‑outcome gains. The association’s recommendation to retain existing quality‑reporting mechanisms reflects a pragmatic approach to incremental improvement rather than wholesale disruption.

The broader implications for the mental‑health ecosystem are significant. Medicare is a primary payer for many inpatient psychiatric beds, and any shift in reimbursement directly influences capacity, staffing, and the ability to adopt evidence‑based practices. Stakeholders—including state Medicaid programs, private insurers, and advocacy groups—will be watching CMS’s response closely, as a balanced rule could preserve access while encouraging efficiency. Conversely, a rule that imposes steep cost pressures may accelerate consolidation, reduce rural service availability, and ultimately impact patient outcomes across the nation.